APOB and diabetes mellitus: The analysis of baseline data between the two groups showed that the time of disease onset, baseline NIHSS score, percentage of diabetes mellitus, WBC level, CRP, and apolipoprotein B level was higher in the END group than in the non-END group, with statistically significant differences (P < 0.05).